Split Fed. Circ. Won't Restore 4 Narcan Patents
Generic drug giant Teva scored a win at the Federal Circuit on Thursday when a divided panel stood by a New Jersey federal judge's invalidation of claims in four patents covering...To view the full article, register now.
Already a subscriber? Click here to view full article